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Introduction: The purpose of this study was to evaluate the short-term 
and long-term results of laparoscopic adrenalectomies carried out in our 
center.
Materials and Methods: A total of 67 laparoscopic adrenalectomies 
were performed during the 10 years between 1995 and 2005 at Shahid 
Labbafinejad Medical Center. A transperitoneal lateral approach was 
used in 65 (97.0%) of the patients, and retroperitoneal approach was used 
in 2 (3.0%). The clinical characteristics and the outcomes were reviewed 
in a retrospective study.
Results: Indications for laparoscopic adrenalectomy in our patients 
were as follows: pheochromocytoma in 28 patients (41.8%), aldosterone-
producing adenoma in 15 (22.4%), pseudocyst in 6 (9.0%), Cushing 
syndrome (macronodular adrenocortical hyperplasia) in 5 (7.5%), 
nonfunctioning adenoma (incidentaloma) in 5 (7.5%), myelolipoma in 2 
(3.0%), almost normal adrenal tissue in 2 (3.0%), adrenal cyst in 2 (3.0%), 
adenocarcinoma in 1 (1.4%), and schwannoma in 1 (1.4%). The mean 
operative time for unilateral cases was 149.0 ± 36.1 minutes. The mean 
intraoperative blood loss was 126 ± 36 mL. Conversion rate to open 
surgery was 7.5%. Reoperation due to hemorrhage was performed in 1 
patient. 
Conclusion: Laparoscopic adrenalectomy is a safe procedure in some 
adrenal tumors and a reasonable option for selected large adrenal tumors 
when complete resection is technically feasible and there is no evidence 
of local invasion.
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INTRODUCTION
During the past decade, 
minimally invasive procedures 
have been increasingly used, 
resulting in their current 
wide application to a variety 
of disorders.(1) Laparoscopic 
adrenalectomy was promptly 
introduced and is now almost 
universally considered to be 
the standard technique for 
the management of benign 
adrenal masses; however, it 
is controversial for large and 
potentially malignant tumors.(2-4)  
We report a series of 67 
laparoscopic adrenalectomies 
carried out during a period of 10 
years in our center. 
MATERIALS AND METHODS
A total of 67 laparoscopic 
adrenalectomies performed 
between 1995 and 2005 were 
reviewed retrospectively. 
Preoperative characteristics of 
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the patients are listed in Table 1. Laparoscopy 
was limited to well-encapsulated masses 
without radiologic evidence of periadrenal 
involvement or obvious lymphadenopathy. 
There were 17 patients (25.5%) among our 67 
cases who had a tumor larger than 6 cm in 
diameter. The most common indication for 
laparoscopic adrenalectomy in our series was 
pheochromocytoma (n = 28) that compromised 
the greatest number with adrenal tumors 
larger than 6 cm (Table 2). Five patients (7.5%) 
were classified as having nonfunctioning 
adrenal tumors. These patients had nonspecific 
abdominal pain, history of hypertension, and 
a slight increase in the preoperative 24-hour 
urine metanephrines. Consequently, they 
underwent adrenalectomy for a presumed 
pheochromocytoma, but pathologic 
examination of their removed adrenal glands 
showed no evidence of pheochromocytoma. 
We had 15 patients (22.4%) with aldosterone-
producing adenoma, all of which were 
larger than 3 cm in diameter. Two patients 
(3.0%) underwent adrenalectomy, but 
pathologic examination of specimen showed 
normal adrenal tissue. They had a history 
of hypertension and low but normal levels 
serum potassium with mild increase in serum 
aldosterone. Imaging findings were indicative 
of a tiny nodule. 
Urinary levels of free cortisol and 
vanilmandelic acid, along with plasma 
levels of adrenocorticotropic hormone, 
dehydroepiandrosterone, 17-hydroxy 
progestrone, testosterone, rennin, and 
aldosterone were measured preoperatively, 
as indicated. Complete hormonal tests were 
performed preoperatively in patients with 
incidentally detected adrenal masses. All of 
the patients underwent abdominal computed 
tomography and magnetic resonance 
imaging. In case of pheochromocytoma, 131 
I-metaiodobenzylguanidine scintigraphy was 
performed in order to detect contralateral or 
extra-adrenal lesions. Correction of metabolic 
derangements in patients with Cushing 
syndrome and hyperaldosteronism, and control 
of pheochromocytoma-induced hypertension 
was achieved with α-adrenergic or β-adrenergic 
blockage before surgical operation. 
In order to perform laparoscopic 
adrenalectomy, retroperitoneal approach was 
used in 2 patients (3.0%) with aldosterone-
producing adenoma and schwannoma during 
the first cases (learning curve period) to 
find out the applicability of the approach. 
Afterwards, lateral transperitoneal approach 
was our routine in 65 patients (97.0%) since 
it had more space to work in and anatomy 
was better during the procedure. All of the 
patients underwent bowel preparation the 
day before the procedure. They were secured 
in a 90-degree lateral position for surgical 
operation. The techniques of the lateral 
transperitoneal approach that we used have 
been previously described.(1,3) In the right 
adrenal tumors, if the tumor size was less 
than 4 cm, the adrenal vein was exposed from 
its origin on the inferior vena cava and was 
clipped or coagulated by bipolar cautery. If 
the adrenal tumor was larger (> 4 cm), we 
Table 1. Preoperative Characteristics of Patients Who 
Underwent Laparoscopic Adrenalectomy*
*Values in parentheses are percents.
Characteristics Values
Number of patients   67
Sex
Male  25 (37.3)
Female  42 (62.8)
Mean age, y                        39.8 ± 11.6 (22 to 61)
Mean tumor size, cm  6.3 ± 3.5 (2 to 13)
Tumor side 
Right  29 (43.3)
Left  37 (55.2)
Both  1 (1.5)
Table 2. Indications for Laparoscopic Adrenalectomy 
Indication Patients (%)
Pheochromocytoma  28 (41.8)
Aldosterone-producing adenoma  15 (22.4)
Cushing syndrome (macronodular 
adrenocortical hyperplasia) 
 5 (7.5)
Pseudocyst   6 (9.0)
Adenocarcinoma  1 (1.4)
Myelolipoma  2 (3.0)
Schwannoma  1 (1.4)
Adrenal cyst  2 (3.0)
Nonfunctioning adenoma (incidentaloma)   5 (7.5)
Almost normal adrenal tissue  2 (3.0)
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tried to coagulate or clip the adrenal vein as 
close to the tumor as possible with special 
care not to avulse the adrenal vein from the 
vena cava. We performed adrenalectomy 
in patients with pseudcysts with thick or 
irregular walls, suspicious of malignancy. We 
also performed adrenalectomy in 2 patients 
with symptomatic large adrenal cysts because 
the cyst compromised most of the adrenal 
gland at laparoscopy. In 1 patient undergoing 
the retroperitoneal approach, an adenoma was 
removed and the normal adrenal gland was 
preserved. 
Data on the patients’ characteristics, hospital 
records, and follow-up visits were collected. 
Improvement of hypertension was defined as 
a lower blood pressure and/or reduction of 
antihypertensive medications. The results were 
presented as percentages and mean ± standard 
deviation, where appropriate. 
RESULTS
Indications for adrenalectomy in our series are 
listed in Table 2, and the operative results are 
shown in Table 3. The diameter of the adrenal 
tumor did not significantly correlate the 
operative time; grouping patients into 17 with 
large tumors (≥ 6 cm in diameter) and 50 with 
tumors (< 6 cm), we did not find significantly 
longer operative times in patients with larger 
tumors (159 ± 32 min versus 145 ± 36 min,  
P = .34). 
The overall intraoperative complication 
rate was 6.0% (4 patients). There were 2 
hypertensive crisis episodes in patients with 
phechromocytoma, 1 bleeding episode in 
a patient with a right adrenal tumor less 
than 6 cm, and 1 iatrogenic injury to the 
ileum in a patient with a history of previous 
surgery. Prompt intraoperative intervention 
in the patients with hypertensive crises 
was performed with a successful control. 
Bleeding was massive in 1 patient and 
required intraoperative blood transfusion and 
conversion. Reoperation due to hemorrhage 
was performed in 1 patient (insufficient 
hemostasis). There was 1 case of ileal injury in 
a patient with a history of previous abdominal 
surgery and dense adhesions, which were 
repaired laparoscopically without any 
postoperative complication (Table 3).
All complications and conversions occurred 
during the first 5 years of our experience, in 
the first 25 patients, and there were no major 
complications in the remaining 42 patients. In 
addition, the mean operative time decreased 
significantly in the last 3 years.
Nasogastric drainage usually remained in the 
end of the procedures and the Foley catheter 
was removed in the morning following the 
operation day. All the patients required 
postoperative analgesics for a mean period of 
2.1 ± 0.6 days (range, 1 to 51 days) and were 
able to resume oral intake after a mean of  
2.0 ± 1.2 days (range, 1 to 4 days). 
Postoperative mean hospital stay was 5.0 ± 2.1 
days (range, 3 to 11 days).
At a mean follow-up of 31 months (range, 2 
to 69 months), improvement of hypertension 
was achieved in 41 of 44 patients (93.1%) with 
pheochromocytoma or hyperaldosteronism. 
After the operation, all of the patients were 
referred to an endocrinologist for evaluation. 
There was no evidence of biochemical relapse 
in hormonally active tumors. One patient 
in whom laparoscopic adrenalectomy was 
attempted to treat adenocarcinoma developed 
local metastasis after 6 months. The size of 
tumor was less than 6 cm and we had not 
diagnosed it preoperatively. There was no 
perioperative mortality and no capsular 
disruption during dissection. 
Table 3. Operative Outcomes of Laparoscopic Adrenalectomy*
*Values in parentheses are minimum and maximum values or 
percentages where appropriate.
†Operative time for unilateral tumors was considered.
‡The patient had bowel adhesion due to appendectomy. Injury was 
repaired laparoscopically with no further problems.
Outcome Parameter Value
Mean operative time, min†  149.0 ± 36.1 (130 to 290)
Right side  165.0 ± 33.6 (150 to 230)
Left side  121.0 ± 39.2 (80 to 290)
Mean blood loss, mL  126 ± 36 (70 to 850)
Conversion to open surgery  5 (7.5)
Reoperation for bleeding  1 (1.4)
Ileal injury‡  1 (1.4)
Hypertension  2 (3.0)
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DISCUSSION
Laparoscopy has become the gold standard 
approach to routine adrenalectomy.(3,5,6) 
Abandoning large incisions and minimizing 
bowel manipulation result in decreased 
preoperative morbidity, shortened hospital 
stay, and rapid functional recovery. 
Concerning the treatment of adrenal 
masses, despite absolute contraindication 
of laparoscopy for large adrenal cortical 
carcinoma with local periadrenal invasion 
or venous thrombus,(1) there is still no 
consensus regarding the maximum tumor 
size for laparoscopy. While the size of an 
adrenal tumor is an important indicator of its 
malignant risk, many large adrenal tumors are 
benign.(2) If size is the only criterion on which 
the operative approach is based, many patients 
with benign large adrenal tumors will have an 
unnecessary open adrenalectomy that might 
increase their morbidity. 
Several surgeons reported successful 
laparoscopy performed in patients with 
adrenal tumors larger than 5 cm.(7-9) They had 
similar results as other surgeons who chose 6 
cm as the cutoff point.(10,11) Data in our series 
also confirm that laparoscopy for tumors 
larger than 6 cm can be performed successfully 
without any increase in conversion rate, 
morbidity, or mortality. In our patients, all 
conversions or malignancies were seen in 
patients with tumors smaller than 6 cm, 
but we emphasize that oncological surgical 
principles should be considered in detail. 
From our data and those just reviewed, it is 
difficult to conclude whether laparoscopy 
offers the same therapeutic efficacy for 
malignant tumors, because in all series, 
malignant tumors are rare. It is very difficult 
to conduct a comparative study of open 
versus laparoscopic adrenalectomy for large 
or malignant tumors in a single center. Also, 
still no reliable preoperative diagnostic test 
exists for determining the malignant potential 
of adrenal tumors.(12) In neither of our patients, 
preoperative laboratory or imaging evaluation 
indicated malignancy. 
During the first five years of our experience, 
we limited the laparoscopic approach to 
benign tumors less than 6 cm in diameter, 
and our first laparoscopic resection of adrenal 
tumors larger than 6 cm were performed after 
we had the experience of 20 laparoscopic 
adrenalectomies in patients with smaller 
adrenal tumors, and thus, we had considerable 
experience with this procedure before we 
encountered patients with this large adrenal 
tumors, and this may have influence our 
results. 
In our study group, the mean size of 
adrenal masses resected by laparoscopic 
adrenalectomy was 6.3 cm (range, 2 cm to 
13 cm). The larger lesions, often involving 
numerous vessels, required special 
perioperative attention, but no increase in 
conversion rate was noted because there 
was no complication or conversion in large 
tumors. Regarding the relationship between 
malignancy and tumor size, some authors 
have reported that tumors larger than 6 cm in 
diameter or weighing more than 100 g  
are highly likely to be malignant.(13,14) 
Furthermore, inhomogeneous features visible 
in a computed tomography scan and elevated 
dehydroepiandrosterone or estradiol levels 
are considered reliable criteria to determine 
the nature of the adrenal tumor. However, 
the malignant potential only becomes true 
when confirmed by evidence of spreading 
beyond the adrenal capsule or adrenal vein 
on pathological examination. Additional 
concerns about port-site metastases and local 
recurrences are theoretically justifiable, but the 
actual risk has remained unknown.(15-17) We did 
not have any port-site metastasis. 
CONCLUSION
Our series confirmed that laparoscopic 
adrenalectomy is a safe and effective 
procedure, associated with minimal morbidity. 
Also, we concluded that most adrenal masses 
are potentially amenable to a laparoscopic 
approach if there is no evidence of periadrenal 
invasion or lymphadenopathy. However, 
meticulous preoperative workup should be 
performed in order to classify the type of 
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lesion and to attain more certainty about its 
anatomical relations. Careful preoperative 
planning will help the surgeon to optimize 
surgical indications and will minimize the 
occurrence of unexpected events during 
surgical operation.
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